medical communications and marketing expertise

t:
+ 44 (0)1477 549 652  e: info@pivotal4pharma.com
Pivotal 4pharma Blog

EBCC breast cancer conference

< Go back to main blog page

Pivotal 4pharma – Life so far and what’s next (19/07/10)
Where have the past six months gone? Time is really flying by as Pivotal 4pharma seeks to establish itself as ‘the hub for breast cancer marketing expertise’. Business so far has been steady, and it has been great to meet new people and provide support to a wide range of companies (from big pharma to small family run businesses), some of whom I had never met or heard of before leaving AstraZeneca. The variety in business has brought new knowledge and a greater understanding of the broader breast cancer market, going far beyond the traditional pharma stuff of drug development and commercialisation. The types of business has also been very varied and includes :

1) Providing strategic advice to advertising agencies putting together pitches for business

2) Detail aid development for a product designed to reduce chemotherapy-induced hair-loss

3) Providing strategic advice to a big pharma company around the design of a key breast cancer clinical trial

4) Technical content development for a breast cancer website update

5) Copy development for exhibition stand messaging

6) Medical information Q and A development

So in addition to my more recent experience in breast cancer drug marketing, I have been able to capitalise on my previous experience in medical writing, medical affairs and medical information. Variety is the ‘spice of life’ as they say.

Since my previous blog I have attended the EBCC breast cancer conference in Barcelona. This was my first visit to a congress as an independent consultant, and it certainly gave a new and refreshing perspective of the value of a breast cancer conference. Instead of spending days on end in company meetings, it was great to attend the main educational sessions and to keep up-to-date on the advances in the field. Whilst there was no big ‘new news’ on the leading breast cancer drugs, there were some excellent sessions, including managing the cardiovascular side effects of treatment, managing metastatic breast cancer and the use of adjuvant taxanes.

Noticeably, EBCC seemed to be less well attended this year, both from a delegate and pharma perspective. There seemed to be fewer exhibition stands, and many of the major players seemed to be occupying smaller stands this year. Also many of familiar faces, both oncologists and pharma staff, who you usually meet year-on-year at congresses were noticeable by their absence. All probably a result of pharma tightening their belts and reducing their congress budget spend.

Whilst talking about congresses, I have just registered to attend the forthcoming San Antonio Breast Cancer Symposium (SABCS), which I am very much looking forward to. SABCS remains the premier breast cancer meeting, where all the major data gets presented for the first time – so it will good to see firsthand which drugs are making big news. When attending San Antonio, I will be available for work opportunities related to the meeting - such as producing meeting reports, competitor reviews and product overviews etc. So if you are too busy to attend all the sessions yourself, or don’t want to spend budget on sending a medical writer to the meeting, then maybe Pivotal 4pharma can provide you with a solution. Just give us a call or drop us a line if you would like to discuss this further.

Wishing you a happy summer holidays season. Don’t hesitate to contact Pivotal 4pharma if you have any work opportunities, or would like to discuss any challenges you are facing in the breast cancer area.

Tim and Ros Sheldon
Testimonial

“His work has always been of the highest quality and standards and I have never known him to miss an agreed deadline.”

Professor John F R Robertson
Pivotal 4pharma provides strategic and tactical medical communications and marketing expertise.